BackgroundRetinal breaks are critical lesions that can lead to retinal detachment and vision loss if not detected and treated early. Automated and precise delineation of retinal breaks using ultra- widefield fundus (UWF) images remain a significant challenge in ophthalmology. ObjectiveThis study aimed to develop and validate a deep learning model based on the PraNet architecture for the accurate delineation of retinal breaks in UWF images, with a particular focus on segmentation performance in retinal break-positive cases. MethodsWe developed a deep learning segmentation model based on the PraNet architecture. This study utilized a dataset consisting of 8,083 cases and a total of 34,867 UWF images. Of these, 960 images contained retinal breaks, while the remaining 33,907 images did not. The dataset was split into 34,713 images for training, 81 for validation, and 73 for testing. The model was trained and validated on this dataset. Model performance was evaluated using both image-wise segmentation metrics (accuracy, precision, recall, Intersection over Union (IoU), dice score, centroid distance score) and lesion-wise detection metrics (sensitivity, positive predictive value). ResultsThe PraNet-based model achieved an accuracy of 0.996, a precision of 0.635, a recall of 0.756, an IoU of 0.539, a dice score of 0.652, and a centroid distance score of 0.081 for pixel-level detection of retinal breaks. The lesion-wise sensitivity was calculated as 0.885, and the positive predictive value (PPV) was 0.742. ConclusionsTo our knowledge, this is the first study to present pixel-level localization of retinal breaks using deep learning on UWF images. Our findings demonstrate that the PraNet-based model provides precise and robust pixel-level segmentation of retinal breaks in UWF images. This approach offers a clinically applicable tool for the precise delineation of retinal breaks, with the potential to improve patient outcomes. Future work should focus on external validation across multiple institutions and integration of additional annotation strategies to further enhance model performance and generalizability.

PurposeTo develop and validate an artificial intelligence (AI)-based model that automatically measures choroidal mass dimensions on B{square}scan ophthalmic ultrasound still images and cine loops. DesignRetrospective diagnostic accuracy study with internal and external validation. ParticipantsThe dataset included 1,822 still images and 283 cine loops of choroidal masses for model development and testing. An additional 182 still images were used for external validation, and 302 control images with other diagnoses were included to assess specificity MethodsA deep convolutional neural network (CNN) based on the U-Net architecture was developed to automatically measure the apical height and basal diameter of choroidal masses on B-scan ultrasound. All still images were manually annotated by expert graders and reviewed by a senior ocular oncologist. Cine loops were analyzed frame by frame and the frame with the largest detected mass dimensions was selected for evaluation. Outcome MeasuresThe primary outcome was the models measurement accuracy, defined by the mean absolute error (MAE) in millimeters, compared to expert manual annotations, for both apical height and basal diameter. Secondary metrics included the Dice coefficient, coefficient of determination (R2), and mean pixel distance between predicted and reference measurements. ResultsOn the internal test set of still images, the model successfully detected the tumor in 99.7% of cases. The mean absolute error (MAE) was 0.38 {+/-} 0.55 mm for apical height (95.1% of measurements <1 mm of the expert annotation) and was 0.99 {+/-} 1.15 mm for basal diameter (64.4% of measurements <1 mm). Linear agreement between predicted and reference measurements was strong, with R2 values of 0.74 for apical height and 0.89 for basal diameter. When applied to the control set of 302 control images, the model demonstrated a moderate false positive rate. On the external validation set, the model maintained comparable accuracy. Among the cine loops, the model detected tumors in 89.4% of cases with comparable accuracy. ConclusionDeep learning can deliver fast, reproducible, millimeter{square}level measurements of choroidal mass dimensions with robust performance across different mass types and imaging sources. These findings support the potential clinical utility of AI-assisted measurement tools in ocular oncology workflows.

BackgroundConvolutional neural networks (CNNs) have emerged to reduce clinical resources and standardize auto-contouring of organs-at-risk (OARs). Although CNNs perform adequately for most patients, understanding when the CNN might fail is critical for effective and safe clinical deployment. However, the limitations of CNNs are poorly understood because of their black-box nature. Explainable artificial intelligence (XAI) can expose CNNs inner mechanisms for classification. Here, we investigate the inner mechanisms of CNNs for segmentation and explore a novel, computational approach to a-priori flag potentially insufficient parotid gland (PG) contours. MethodsFirst, 3D UNets were trained in three PG segmentation situations using (1) synthetic cases; (2) 1925 clinical computed tomography (CT) scans with typical and (3) more consistent contours curated through a previously validated auto-curation step. Then, we generated attribution maps for seven XAI methods, and qualitatively assessed them for congruency between simulated and clinical contours, and how much XAI agreed with expert reasoning. To objectify observations, we explored persistent homology intensity filtrations to capture essential topological characteristics of XAI attributions. Principal component (PC) eigenvalues of Euler characteristic profiles were correlated with spatial agreement (Dice-Sorensen similarity coefficient; DSC). Evaluation was done using sensitivity, specificity and the area under receiver operating characteristic (AUROC) curve on an external AAPM dataset, where as proof-of-principle, we regard the lowest 15% DSC as insufficient. ResultsPatternNet attributions (PNet-A) focused on soft-tissue structures, whereas guided backpropagation (GBP) highlighted both soft-tissue and high-density structures (e.g. mandible bone), which was congruent with synthetic situations. Both methods typically had higher/denser activations in better auto-contoured medial and anterior lobes. Curated models produced "cleaner" gradient class-activation mapping (GCAM) attributions. Quantitative analysis showed that PC{lambda}1 of guided GCAMs (GGCAM) Euler characteristic (EC) profile had good predictive value (sensitivity>0.85, specificity>0.9) of DSC for AAPM cases, with AUROC=0.66, 0.74, 0.94, 0.83 for GBP, GCAM, GGCAM and PNet-A. For for {lambda}1<-1.8e3 of GGCAMs EC-profile, 87% of cases were insufficient. ConclusionsGBP and PNet-A qualitatively agreed most with expert reasoning on directly (structure borders) and indirectly (proxies used for identifying structure borders) important features for PG segmentation. Additionally, this work investigated as proof-of-principle how topological data analysis could possibly be used for quantitative XAI signal analysis to a-priori mark potentially inadequate CNN-segmentations, using only features from inside the predicted PG. This work used PG as a well-understood segmentation paradigm and may extend to target volumes and other organs-at-risk.

IntroductionEnlarged perivascular spaces (PVS) are imaging markers of cerebral small vessel disease (CSVD) that are associated with age, disease phenotypes, and overall health. Quantification of PVS is challenging but necessary to expand an understanding of their role in cerebrovascular pathology. Accurate and automated segmentation of PVS on T1-weighted images would be valuable given the widespread use of T1-weighted imaging protocols in multisite clinical and research datasets. MethodsWe introduce segcsvdPVS, a convolutional neural network (CNN)-based tool for automated PVS segmentation on T1-weighted images. segcsvdPVS was developed using a novel hierarchical approach that builds on existing tools and incorporates robust training strategies to enhance the accuracy and consistency of PVS segmentation. Performance was evaluated using a comprehensive evaluation strategy that included comparison to existing benchmark methods, ablation-based validation, accuracy validation against manual ground truth annotations, correlation with age-related PVS burden as a biological benchmark, and extensive robustness testing. ResultssegcsvdPVS achieved strong object-level performance for basal ganglia PVS (DSC = 0.78), exhibiting both high sensitivity (SNS = 0.80) and precision (PRC = 0.78). Although voxel-level precision was lower (PRC = 0.57), manual correction improved this by only ~3%, indicating that the additional voxels reflected primary boundary- or extent-related differences rather than correctable false positive error. For non-basal ganglia PVS, segcsvdPVS outperformed benchmark methods, exhibiting higher voxel-level performance across several metrics (DSC = 0.60, SNS = 0.67, PRC = 0.57, NSD = 0.77), despite overall lower performance relative to basal ganglia PVS. Additionally, the association between age and segmentation-derived measures of PVS burden were consistently stronger and more reliable for segcsvdPVS compared to benchmark methods across three cohorts (test6, ADNI, CAHHM), providing further evidence of the accuracy and consistency of its segmentation output. ConclusionssegcsvdPVS demonstrates robust performance across diverse imaging conditions and improved sensitivity to biologically meaningful associations, supporting its utility as a T1-based PVS segmentation tool.

In groups of patients suffering from schizophrenia (SZ), redox dysregulation was reported in both peripheral fluids and brain. It has been hypothesized that such dysregulation, including alterations of the glutathione (GSH) cycle could participate in the brain white matter (WM) abnormalities in SZ due to the oligodendrocytes susceptibility to oxidative stress. In this study we aim to assess the differences between 82 schizophrenia patients (PT) and 86 healthy controls (HC) in GSH-redox peripheral blood markers: GSH peroxidase (GPx), reductase (GR) enzymatic activities and their ratio (GPx/GR-ratio), evaluating the hypotheses that alterations in the homeostasis of the systemic GSH cycle may be associated with pathological mechanisms in the brain WM in PT. To do so, we employ the advanced diffusion MRI methods: Diffusion Kurtosis Imaging (DKI) and White Matter Tract Integrity-Watson (WMTI-W), which provide excellent sensitivity to demyelination and neuroinflammation. We show that GPx levels are higher (p=0.00041) in female control participants and decrease with aging (p=0.026). We find differences between PT and HC in the association of GR and mean kurtosis (MK, p<0.0001). Namely, lower MK was associated with higher blood GR activity in HC, but not in PT, suggesting that high GR activity (a hallmark of reductive stress) in HC was linked to changes in myelin integrity. However, GSH-redox peripheral blood markers did not explain the WM anomalies detected in PT, or the design of the present study could not detect subtle phenomenon, if present.

BackgroundOptimisation of Deep Brain Stimulation (DBS) settings is a key aspect in achieving clinical efficacy in movement disorders, such as the Parkinsons disease. Modern techniques attempt to solve the problem through data-intensive statistical and machine learning approaches, adding significant overhead to the existing clinical workflows. Here, we present an optimisation approach for DBS electrode contact and current selection, grounded in routinely collected MRI data, well-established tools (Lead-DBS) and, optionally, clinical review records. MethodsThe pipeline, packaged in a cross-platform tool, uses lead reconstruction data and simulation of volume of tissue activated to estimate the contacts in optimal position relative to the target structure, and suggest optimal stimulation current. The tool then allows further interactive user optimisation of the current settings. Existing electrode contact evaluations can be optionally included in the calculation process for further fine-tuning and adverse effect avoidance. ResultsBased on a sample of 177 implanted electrode reconstructions from 89 Parkinsons disease patients, we demonstrate that DBS parameter setting by our algorithm is more effective in covering the target structure (Wilcoxon p<6e-12, Hedges g>0.34) and minimising electric field leakage to neighbouring regions (p<2e-15, g>0.84) compared to expert parameter settings. ConclusionThe proposed automated method, for optimisation of the DBS electrode contact and current selection shows promising results and is readily applicable to existing clinical workflows. We demonstrate that the algorithmically selected contacts perform better than manual selections according to electric field calculations, allowing for a comparable clinical outcome without the iterative optimisation procedure.

Background and AimsIn cardiovascular magnetic resonance (CMR), myocardial native T1 mapping enables quantitative, non-invasive tissue characterization and is sensitive to subclinical changes in myocardial structure and composition. We investigated how age, sex, and cardiometabolic risk factors are associated with myocardial T1 in a population-based analysis within the German National Cohort (NAKO). MethodsThis cross-sectional study included 29,573 prospectively enrolled participants who underwent CMR-based midventricular T1 mapping at 3.0 T, alongside clinical phenotyping. After artificial intelligence-assisted myocardial segmentation, a subset of 9,162 outliers was subjected to manual quality control according to clinical evaluation standards. Associations with cardiometabolic risk factors, identified through self-reported medical history, clinical chemistry, and blood pressure measurements, were evaluated using adjusted linear regression models. ResultsWomen had higher T1 values than men, with sex differences progressively declining with age. T1 was significantly elevated in individuals with diabetes ({beta}=3.91 ms; p<0.001), kidney disease ({beta}=3.44 ms; p<0.001), and current smoking ({beta}=6.67 ms; p<0.001). Conversely, hyperlipidaemia was significantly associated with lower T1 ({beta}=-4.41 ms; p<0.001). Associations with hypertension showed a sex-specific pattern: T1 was lower in women but increased with hypertension severity in men. ConclusionsMyocardial native T1 varies by sex and age and shows associations with major cardiometabolic risk factors. Notably, lower T1 times in participants with hyperlipidaemia may indicate a direct effect of blood lipids on the heart. Our findings support the utility of T1 mapping as a sensitive marker of early myocardial changes and highlight the sex-specific interplay between cardiometabolic health and myocardial tissue composition. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/25331651v1_ufig1.gif" ALT="Figure 1"> View larger version (44K): [email protected]@131514borg.highwire.dtl.DTLVardef@d03877org.highwire.dtl.DTLVardef@2b2fec_HPS_FORMAT_FIGEXP M_FIG C_FIG Key QuestionHow are age, sex, and cardiometabolic risk factors associated with myocardial native T1, a quantitative magnetic resonance imaging marker of myocardial tissue composition, in a large-scale population-based evaluation within the German National Cohort (NAKO)? Key FindingT1 relaxation times were higher in women and gradually converged between sexes with age. Diabetes, kidney disease, smoking, and hypertension in men were associated with prolonged T1 times. Unexpectedly, hyperlipidaemia and hypertension in women showed a negative association with T1. Take-Home MessageNative T1 mapping is sensitive to subclinical myocardial changes and reflects a close interplay between metabolic and myocardial health. It reveals marked age-dependent sex differences and sex-specific responses in myocardial tissue composition to cardiometabolic risk factors.

BackgroundFree-running (FR) cardiac MRI enables free-breathing ECG-free fully dynamic 5D (3D spatial+cardiac+respiration dimensions) imaging but poses significant challenges for clinical integration due to the volume and complexity of image analysis. Existing segmentation methods are tailored to 2D cine or static 3D acquisitions and cannot leverage the unique spatial-temporal wealth of FR data. PurposeTo develop and validate a deep learning (DL)-based segmentation framework for isotropic 3D+cardiac cycle FR cardiac MRI that enables accurate, fast, and clinically meaningful anatomical and functional analysis. MethodsFree-running, contrast-free bSSFP acquisitions at 1.5T and contrast-enhanced GRE acquisitions at 3T were used to reconstruct motion-resolved 5D datasets. From these, the end-expiratory respiratory phase was retained to yield fully isotropic 4D datasets. Automatic propagation of a limited set of manual segmentations was used to segment the left and right ventricular blood pool (LVB, RVB) and left ventricular myocardium (LVM) on reformatted short-axis (SAX) end-systolic (ES) and end-diastolic (ED) images. These were used to train a 3D nnU-Net model. Validation was performed using geometric metrics (Dice similarity coefficient [DSC], relative volume difference [RVD]), clinical metrics (ED and ES volumes, ejection fraction [EF]), and physiological consistency metrics (systole-diastole LVM volume mismatch and LV-RV stroke volume agreement). To assess the robustness and flexibility of the approach, we evaluated multiple additional DL training configurations such as using 4D propagation-based data augmentation to incorporate all cardiac phases into training. ResultsThe main proposed method achieved automatic segmentation within a minute, delivering high geometric accuracy and consistency (DSC: 0.94 {+/-} 0.01 [LVB], 0.86 {+/-} 0.02 [LVM], 0.92 {+/-} 0.01 [RVB]; RVD: 2.7%, 5.8%, 4.5%). Clinical LV metrics showed excellent agreement (ICC > 0.98 for EDV/ESV/EF, bias < 2 mL for EDV/ESV, < 1% for EF), while RV metrics remained clinically reliable (ICC > 0.93 for EDV/ESV/EF, bias < 1 mL for EDV/ESV, < 1% for EF) but exhibited wider limits of agreement. Training on all cardiac phases improved temporal coherence, reducing LVM volume mismatch from 4.0% to 2.6%. ConclusionThis study validates a DL-based method for fast and accurate segmentation of whole-heart free-running 4D cardiac MRI. Robust performance across diverse protocols and evaluation with complementary metrics that match state-of-the-art benchmarks supports its integration into clinical and research workflows, helping to overcome a key barrier to the broader adoption of free-running imaging.

ImportanceBrain MRI is the main imaging modality for pediatric brain tumors (PBTs); however, incomplete MRI exams are common in pediatric neuro-oncology settings and pose a barrier to the development and application of deep learning (DL) models, such as tumor segmentation and prognostic risk estimation. ObjectiveTo evaluate DL-based strategies (image-dropout training and generative image synthesis) and heuristic imputation approaches for handling missing MRI sequences in PBT imaging from clinical acquisition protocols, and to determine their impact on segmentation accuracy and prognostic risk estimation. DesignThis cohort study included 715 patients from the Childrens Brain Tumor Network (CBTN) and BraTS-PEDs, and 43 patients with longitudinal MRI (157 timepoints) from PNOC003/007 clinical trials. We developed a dropout-trained nnU-Net tumor segmentation model that randomly omitted FLAIR and/or T1w (no contrast) sequences during training to simulate missing inputs. We compared this against three imputation approaches: a generative model for image synthesis, copy-substitution heuristics, and zeroed missing inputs. Model-generated tumor volumes from each segmentation method were compared and evaluated against ground truth (expert manual segmentations) and incorporated into time-varying Cox regression models for survival analysis. SettingMulti-institutional PBT datasets and longitudinal clinical trial cohorts. ParticipantsAll patients had multi-parametric MRI and expert manual segmentations. The PNOC cohort had a median of three imaging timepoints and associated clinical data. Main Outcomes and MeasuresSegmentation accuracy (Dice scores), image quality metrics for synthesized scans (SSIM, PSNR, MSE), and survival discrimination (C-index, hazard ratios). ResultsThe dropout model achieved robust segmentation under missing MRI, with [&le;]0.04 Dice drop and a stable C-index of 0.65 compared to complete-input performance. DL-based MRI synthesis achieved high image quality (SSIM > 0.90) and removed artifacts, benefiting visual interpretability. Performance was consistent across cohorts and missing data scenarios. Conclusion and RelevanceModality-dropout training yields robust segmentation and risk-stratification on incomplete pediatric MRI without the computational and clinical complexity of synthesis approaches. Image synthesis, though less effective for these tasks, provides complementary benefits for artifact removal and qualitative assessment of missing or corrupted MRI scans. Together, these approaches can facilitate broader deployment of AI tools in real-world pediatric neuro-oncology settings.

With increasing interest in studying biological systems across spatial scales--from centimetres down to nanometres--histology continues to be the gold standard for tissue imaging at cellular resolution, providing an essential bridge between macroscopic and nanoscopic analysis. However, its inherently destructive and two-dimensional nature limits its ability to capture the full three-dimensional complexity of tissue architecture. Here we show that phase-contrast X-ray microscopy can enable three-dimensional virtual histology with subcellular resolution. This technique provides direct quantification of electron density without restrictive assumptions, allowing for direct characterisation of cellular nuclei in a standard laboratory setting. By combining high spatial resolution and soft tissue contrast, with automated segmentation of cell nuclei, we demonstrated virtual H&E staining using machine learning-based style transfer, yielding volumetric datasets compatible with existing histopathological analysis tools. Furthermore, by integrating electron density and the sensitivity to nanometric features of the dark field contrast channel, we achieve stain-free, high-content imaging capable of distinguishing nuclei and extracellular matrix.